Pioneer Group

𝐁𝐢𝐠 𝐍𝐞𝐰𝐬: Pioneer Group & Novo Nordisk Launch Golden Ticket Programme We’re teaming up with Novo Nordisk—a global healthcare leader specialising in chronic disease treatments—to accelerate breakthroughs in cardiometabolic health. 🎟️ 𝐓𝐡𝐞 𝐏𝐫𝐢𝐳𝐞: Early-stage biotech companies developing novel therapies for diabetes, obesity, cardiovascular diseases, rare blood and rare endocrine disorders, and metabolic disorders can receive: ✔️ 12 months of rent-free lab space at one of Pioneer Group’s sites ✔️ Expert mentoring from Novo Nordisk’s drug discovery and development teams ✔️ Access to Pioneer Group’s Venture Programmes and investment networks This is your chance to transform healthcare with your innovative therapies. Apply today to be part of the next wave of life-changing therapies. Applications close on November 15th. Learn More & Apply 👉 https://lnkd.in/dxfyicvr

𝐅𝐢𝐧𝐚𝐥 𝐖𝐞𝐞𝐤 𝐭𝐨 𝐀𝐩𝐩𝐥𝐲: Maximize the commercial potential of your healthcare startup or research with the Pioneer & Novo Nordisk Golden Ticket Programme. 𝐖𝐡𝐲 𝐈𝐭'𝐬 𝐚 𝐆𝐚𝐦𝐞 𝐂𝐡𝐚𝐧𝐠𝐞𝐫: We’re offering you 12 months of rent-free lab space, world-class mentorship from Novo Nordisk, and access to our expert-led ecosystem to empower innovators like you. 🔬 𝐖𝐡𝐨 𝐒𝐡𝐨𝐮𝐥𝐝 𝐀𝐩𝐩𝐥𝐲: 𝐀𝐜𝐚𝐝𝐞𝐦𝐢𝐜𝐬: Transform research into solutions with tailored business support. 𝐒𝐭𝐚𝐫𝐭-𝐮𝐩𝐬: Scale with top-tier resources and strategic mentorship. 𝐅𝐨𝐜𝐮𝐬 𝐀𝐫𝐞𝐚𝐬: ◾Diabetes ◾Obesity ◾Cardiovascular Disease ◾Metabolic Disease Co-morbidities & Rare Disease ◾Drug Discovery & Enabling Technology 🤝 Can't Apply? Share this post with those who can and help drive life-changing advancements. ⏰ 𝐔𝐫𝐠𝐞𝐧𝐭: Applications close November 15th—don’t miss your chance to supercharge your innovations. 👉 Apply Now:https://lnkd.in/efs8qdEQ

𝐏𝐢𝐨𝐧𝐞𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐬: Innovations for a Sustainable Future As the world continues to experience unprecedented climate events, Pioneer Group presents critical insights and solutions for sustainable innovation. Join us for expert-led webinars on groundbreaking research and strategies driving positive change. 𝐄𝐯𝐞𝐧𝐭 𝐒𝐞𝐫𝐢𝐞𝐬 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰 🌍 November 13: 𝘌𝘹𝘱𝘭𝘰𝘳𝘪𝘯𝘨 𝘎𝘳𝘦𝘦𝘯 𝘐𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯 𝘵𝘩𝘳𝘰𝘶𝘨𝘩 𝘗𝘢𝘵𝘦𝘯𝘵 𝘋𝘢𝘵𝘢 In partnership with Appleyard Lees IP LLP explore the Inside Green Innovation report to see what patent data reveals about global green tech breakthroughs—and the future of sustainable innovation. 🥩 November 21: 𝘈𝘭𝘵𝘦𝘳𝘯𝘢𝘵𝘪𝘷𝘦 𝘗𝘳𝘰𝘵𝘦𝘪𝘯𝘴 – 𝘛𝘩𝘦 𝘍𝘶𝘵𝘶𝘳𝘦 𝘰𝘧 𝘚𝘶𝘴𝘵𝘢𝘪𝘯𝘢𝘣𝘭𝘦 𝘍𝘰𝘰𝘥 𝘗𝘳𝘰𝘥𝘶𝘤𝘵𝘪𝘰𝘯 Join us in launching our industry briefing note, ‘Alternative Proteins: The Future of Sustainable & Healthy Food Production’ - a report that reveals actionable reform for food production. 🧪 November 22: 𝘛𝘰𝘸𝘢𝘳𝘥𝘴 𝘢 𝘚𝘶𝘴𝘵𝘢𝘪𝘯𝘢𝘣𝘭𝘦 𝘊𝘩𝘦𝘮𝘪𝘤𝘢𝘭𝘴 𝘐𝘯𝘥𝘶𝘴𝘵𝘳𝘺 Discover practical steps for transitioning to sustainable chemicals and fossil-free feedstocks—including insights from our latest industry briefing note. 𝐖𝐡𝐲 𝐀𝐭𝐭𝐞𝐧𝐝? ▪️𝐆𝐚𝐢𝐧 𝐄𝐱𝐩𝐞𝐫𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: Hear from leaders in each sector and understand the practical implications of their findings. ▪️𝐍𝐞𝐭𝐰𝐨𝐫𝐤 𝐢𝐧 𝐑𝐞𝐚𝐥-𝐓𝐢𝐦𝐞: Participate in Q&As and interact directly with industry pioneers. ▪️𝐒𝐭𝐚𝐲 𝐀𝐡𝐞𝐚𝐝 𝐨𝐟 𝐓𝐫𝐞𝐧𝐝: Equip yourself with knowledge of the latest data, regulations, and strategies for sustainability. Secure Your Spot 👉https://lnkd.in/eGDfS7CU

𝐀𝐮𝐭𝐮𝐦𝐧 𝐁𝐮𝐝𝐠𝐞𝐭 𝟐𝟎𝟐𝟒: The government pledges funding for R&D   Pioneer Group has welcomed the support for the life sciences and planetary health sectors announced in the budget today (30 October), with Chancellor Rachel Reeves pledging funding for research and development. The government will also maintain current rates of R&D tax relief to drive innovation, and has confirmed up to £520 million for a new Life Sciences Innovative Manufacturing Fund.    At today’s Budget Focus Group at Kent Science Park with BBC Radio Kent and Federation of Small Businesses (FSB), Pioneer Group’s Corporate Development Director Miranda Knaggs reacted to the measures unveiled:   “The announcements made today will help improve investor confidence and ensure the UK is recognised as a life sciences superpower. It will also help the UK to attract talent and be seen as a great place to work.”    The Budget Focus Group event brought together business owners and representatives from across Kent to discuss what they wanted from the budget and react to the announcements made.    👉Discover the full story: https://lnkd.in/d9qtKexj

Today, Kent Science Park is pleased to be hosting BBC Radio Kent and Federation of Small Businesses (FSB) for a Budget Focus Group featuring Pioneer’s Corporate Development Director, Miranda Knaggs and representatives from other local businesses.    Miranda is speaking to Michael Keohan, Political Reporter at BBC Radio Kent, live on the radio about what the UK life sciences sector needs from today’s budget. Following the budget, there will be a panel discussion reacting to the announcements made.    We’d like to thank FSB and Tim Aker for organising the event.   Pictured (L to R): Will Roffey, Executive Producer, BBC Radio Kent; Jo Webber, Office & Events Administrator at Kent Science Park, Louise Turner, Commercial Director at Kent Science Park, and Michael Keohan, Political Reporter, BBC Radio Kent. 

𝐕𝐢𝐜𝐭𝐨𝐫𝐢𝐚 𝐇𝐨𝐮𝐬𝐞: Where London’s Heritage Meets the Future of Science Innovation On the cusp of our grand opening, Victoria House in Bloomsbury’s Knowledge Quarter is poised to be more than just a lab space— It’s a landmark blending London’s historic charm with tomorrow’s scientific breakthroughs. 𝐖𝐡𝐲 𝐕𝐢𝐜𝐭𝐨𝐫𝐢𝐚 𝐇𝐨𝐮𝐬𝐞 𝐌𝐚𝐭𝐭𝐞𝐫𝐬 𝐀 𝐋𝐞𝐠𝐚𝐜𝐲 𝐨𝐟 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Set in a Grade-II listed building, VH combines London’s heritage with an environment expertly tailored to support world-changing research. 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐬𝐞𝐝 𝐟𝐨𝐫 𝐆𝐫𝐨𝐰𝐭𝐡: With flexible lab spaces, venture support, and expert resources, companies can scale without ever needing to relocate. 𝐀𝐭 𝐭𝐡𝐞 𝐇𝐞𝐚𝐫𝐭 𝐨𝐟 𝐚 𝐆𝐥𝐨𝐛𝐚𝐥 𝐇𝐮𝐛: Located steps away from institutions like UCL and GSK, Victoria House will catalyse collaboration. Explore Victoria House 👉https://lnkd.in/eMr6Duum

𝐓𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐀𝐈 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐬 𝐇𝐞𝐫𝐞: 55 Start-Ups Selected for Our Pre-accelerator AI in healthcare has surged, outpacing deal growth in the tech sector over the last five years. ⏩Now, 55 start-ups are advancing in our AI in Health Accelerator with Innovate UK. These pioneers are tackling critical challenges like genetic diseases, neurological disorders, and cardiovascular health. In partnership with Medical Research Council and The Helix Way, we’re helping bring these breakthrough ideas to life. 𝐊𝐞𝐲 𝐒𝐭𝐚𝐭𝐬: ✔️127 applications reviewed ✔️112 companies assessed ✔️55 startups advancing Stay tuned to follow their AI healthcare journey 👉 Find out more https://lnkd.in/ecFvy8iz

𝐀 𝐆𝐨𝐥𝐝𝐞𝐧 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐟𝐨𝐫 𝐀𝐜𝐚𝐝𝐞𝐦𝐢𝐜 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫𝐬 Turning groundbreaking innovation into a commercial success can feel daunting. Many academic researchers face the same challenge: World-class science but limited business acumen. It's a key reason why around 50% of spinouts fail before they become profitable. 𝐓𝐡𝐞 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧? The Pioneer & Novo Nordisk Golden Ticket Programme. ✔️Mentorship from Novo Nordisk’s drug discovery teams ✔️Expert support designed to derisk commercial viability ✔️12 months of rent-free lab space 𝐃𝐨 𝐲𝐨𝐮 𝐤𝐧𝐨𝐰 𝐚𝐜𝐚𝐝𝐞𝐦𝐢𝐜 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫𝐬, 𝐬𝐩𝐢𝐧𝐨𝐮𝐭𝐬, 𝐨𝐫 𝐬𝐭𝐚𝐫𝐭𝐮𝐩𝐬 𝐫𝐞𝐚𝐝𝐲 𝐭𝐨 𝐭𝐚𝐤𝐞 𝐭𝐡𝐞 𝐥𝐞𝐚𝐩? Share this opportunity to ensure they don't miss out on this once-in-a-liftetime programme. Applications close November 15th. Apply Now 👇 https://lnkd.in/eKPMDRkZ

What Start-Up Support is Available for Budding Life Science Businesses? 𝐃𝐢𝐝 𝐲𝐨𝐮 𝐤𝐧𝐨𝐰? Life sciences start-ups have surged by 13% in the last five years, driven by advances in biotechnology and pharmaceuticals. But in the same period securing the funding and expertise needed has become a bigger challenge. 𝐎𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐛𝐫𝐞𝐚𝐤𝐬 𝐝𝐨𝐰𝐧 𝐭𝐡𝐞 𝐜𝐫𝐢𝐭𝐢𝐜𝐚𝐥 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐭𝐡𝐚𝐭 𝐜𝐚𝐧 𝐡𝐞𝐥𝐩 𝐲𝐨𝐮 𝐥𝐚𝐮𝐧𝐜𝐡, 𝐬𝐜𝐚𝐥𝐞, 𝐚𝐧𝐝 𝐬𝐮𝐜𝐜𝐞𝐞𝐝. 𝐑𝐞𝐚𝐝𝐲 𝐭𝐨 𝐥𝐚𝐮𝐧𝐜𝐡? Discover how to de-risk your venture and secure Series A investments. 𝐍𝐞𝐞𝐝 𝐭𝐨 𝐭𝐚𝐤𝐞 𝐭𝐡𝐞 𝐧𝐞𝐱𝐭 𝐬𝐭𝐞𝐩? Gain insights, develop your product, and get investment-ready. 𝐋𝐨𝐨𝐤𝐢𝐧𝐠 𝐭𝐨 𝐬𝐜𝐚𝐥𝐞? Overcome growing pains and expand your business for long-term success. 𝐅𝐢𝐧𝐝 𝐨𝐮𝐭 𝐡𝐨𝐰 𝐲𝐨𝐮 𝐜𝐚𝐧 𝐚𝐜𝐜𝐞𝐥𝐞𝐫𝐚𝐭𝐞 𝐲𝐨𝐮𝐫 𝐠𝐫𝐨𝐰𝐭𝐡 𝐰𝐢𝐭𝐡 𝐨𝐮𝐫 𝐜𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐨𝐩𝐭𝐢𝐨𝐧𝐬. Full article here 👇 https://lnkd.in/ecKDu69D

𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐀𝐃𝐇𝐃 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬: The QbTest's Remarkable Impact Untreated, undiagnosed and poorly managed ADHD leads to significant development and mental disorders. As part of ADHD Awareness Month, we’re proud to support Health Innovation East Midlands in championing the life-changing success of the QbTest for ADHD Diagnosis. HIEM piloted the use of QbTest within three NHS mental health trusts as an objective assessment tool. 𝐒𝐢𝐧𝐜𝐞 𝐢𝐭𝐬 𝐥𝐚𝐮𝐧𝐜𝐡, 𝐭𝐡𝐞 𝐐𝐛𝐓𝐞𝐬𝐭 𝐡𝐚𝐬 𝐫𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐢𝐬𝐞𝐝 𝐀𝐃𝐇𝐃 𝐬𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐚𝐜𝐫𝐨𝐬𝐬 𝐄𝐧𝐠𝐥𝐚𝐧𝐝: ▪️ 95,000 hours of clinical time saved ▪️ £38.5M in cost savings for the NHS ▪️ 71,000+ children and young people benefiting from more accurate diagnoses This innovation continues to spread, and it has been adopted by a further 10 NHS trusts nationwide. It's already helped to transform thousands of lives - and will continue to reshape the way we deliver care for ADHD. Learn more about QbTest’s impact 👇 https://lnkd.in/eX_cVpcJ